PTGS2 and hepatocellular carcinoma: It suppresses pro-inflammatory mediators, including nuclear factor-κB (NF-κB), cyclooxygenase-2 (COX-2), TNF-α, IL-1β, and IL-6, which are overexpressed in HCC, improving the tumor microenvironment’s oxidative and inflammatory state [98,99].